Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuhei So

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Addictive Behaviors Reports|March 21, 2025
Association of gambling activities and modalities with problem gambling in Japan: A nationwide cross-sectional online survey-based studyTakashi Yoshioka, Ryuhei So, Tatsuya Noda, et al.
Plos One|January 26, 2019
Physician characteristics associated with proper assessment of overstated conclusions in research abstracts: A secondary analysis of a randomized controlled trialYasushi Tsujimoto, Takuya Aoki, Kiyomi Shinohara, et al.
Psychiatry and Clinical Neurosciences|July 28, 2025
Efficacy and safety of a digital therapeutic for alcohol dependence: A multicenter, open-label, randomized controlled trialRyuhei So, Kazuhiro Nouso, Sachio Matsushita, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 23, 2021
Digital therapeutics for essential hypertension using a smartphone application: A randomized, open-label, multicenter pilot studyKazuomi Kario, Akihiro Nomura, Ayaka Kato, et al.
Plos One|June 20, 2020
Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J)Kohei Kitagawa, Ryuhei So, Nobuyuki Nomura, et al.
Psychopharmacology|August 6, 2024
Impact of clozapine once-daily versus multiple-daily dosing regimen on relapse in patients with treatment-resistant schizophrenia: A 1-year retrospective cohort studyMasaru Tsukahara, Ryuhei So, Kohei Kitagawa, et al.
BMC Public Health|June 26, 2024
National burden of gambling in Japan: an estimation from an online-based cross-sectional investigation and national epidemiological surveyChiyoung Hwang, Ryuhei So, Nozomu Hashimoto, et al.
Schizophrenia Research|January 27, 2022
Association between subjective distress and symptom domains in patients with treatment-resistant schizophrenia receiving clozapineMasaru Tsukahara, Ryuhei So, Nobuyuki Nomura, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 21, 2020
A multicenter clinical trial to assess the efficacy of the digital therapeutics for essential hypertension: Rationale and design of the HERB-DH1 trialKazuomi Kario, Akihiro Nomura, Noriko Harada, et al.
International Clinical Psychopharmacology|January 25, 2021
Longitudinal changes in antipsychotic dose in patients treated with long-acting injectable second-generation antipsychoticsNozomi Nakajima, Nao Mizoe, Fuminari Misawa, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Addictive Behaviors Reports|March 21, 2025
Association of gambling activities and modalities with problem gambling in Japan: A nationwide cross-sectional online survey-based studyTakashi Yoshioka, Ryuhei So, Tatsuya Noda, et al.
Plos One|January 26, 2019
Physician characteristics associated with proper assessment of overstated conclusions in research abstracts: A secondary analysis of a randomized controlled trialYasushi Tsujimoto, Takuya Aoki, Kiyomi Shinohara, et al.
Psychiatry and Clinical Neurosciences|July 28, 2025
Efficacy and safety of a digital therapeutic for alcohol dependence: A multicenter, open-label, randomized controlled trialRyuhei So, Kazuhiro Nouso, Sachio Matsushita, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 23, 2021
Digital therapeutics for essential hypertension using a smartphone application: A randomized, open-label, multicenter pilot studyKazuomi Kario, Akihiro Nomura, Ayaka Kato, et al.
Plos One|June 20, 2020
Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J)Kohei Kitagawa, Ryuhei So, Nobuyuki Nomura, et al.
Psychopharmacology|August 6, 2024
Impact of clozapine once-daily versus multiple-daily dosing regimen on relapse in patients with treatment-resistant schizophrenia: A 1-year retrospective cohort studyMasaru Tsukahara, Ryuhei So, Kohei Kitagawa, et al.
BMC Public Health|June 26, 2024
National burden of gambling in Japan: an estimation from an online-based cross-sectional investigation and national epidemiological surveyChiyoung Hwang, Ryuhei So, Nozomu Hashimoto, et al.
Schizophrenia Research|January 27, 2022
Association between subjective distress and symptom domains in patients with treatment-resistant schizophrenia receiving clozapineMasaru Tsukahara, Ryuhei So, Nobuyuki Nomura, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 21, 2020
A multicenter clinical trial to assess the efficacy of the digital therapeutics for essential hypertension: Rationale and design of the HERB-DH1 trialKazuomi Kario, Akihiro Nomura, Noriko Harada, et al.
International Clinical Psychopharmacology|January 25, 2021
Longitudinal changes in antipsychotic dose in patients treated with long-acting injectable second-generation antipsychoticsNozomi Nakajima, Nao Mizoe, Fuminari Misawa, et al.
Pageof 8